CATHERINE MUROMBEDZI
HEALTH CORRESPONDENT
In a significant step towards combating tuberculosis (TB) in Nigeria, 333 Truenat devices have been deployed across the country. This innovative solution, supported by the Global Fund and the Nigerian Ministry of Health, aims to enhance TB and Drug-Resistant TB (DR-TB) diagnostics in peripheral facilities, Molbio Diagnostics announced in a Press release.The Challenge of TB in NigeriaNigeria accounts for a staggering 75% of the global missing TB cases and 70% of missing DR-TB cases. One of the primary reasons for this low case detection rate has been the limited access to rapid molecular testing facilities, particularly in remote and resource-limited settings.A game-changing solution, the Truenat device, developed by Molbio Diagnostics is a portable, battery-operated molecular diagnostic tool designed for point-of-care testing. This innovative device can be used at the community level, providing rapid and accurate results, making it an ideal solution for remote and resource-limited settings.IMPACT The deployment of Truenat devices is expected to significantly improve TB detection rates and treatment outcomes. With the capacity to test 8,000 more people per day and 2 million more people per year, this initiative will enable the National Tuberculosis, Leprosy and Buruli Ulcer Programme (NTBLCP) to reach more people and provide timely care.TRAINING To ensure the effective use of the Truenat devices, Molbio Diagnostics and NTBLCP are collaborating on country-wide end-user training and installation. This training will empower healthcare workers to use the devices confidently, ensuring smooth service delivery and accurate diagnostics.BRIGHTER FUTURE The deployment of Truenat devices marks a significant milestone in Nigeria’s fight against TB. With this innovative solution, Nigeria is poised to make significant strides in improving TB detection rates, treatment outcomes, and, ultimately, public health outcomes. Feedback: [email protected]

